LEXEO Therapeutics
LEXEO Therapeutics is a New York City-based, clinical-stage gene therapy company focused on addressing some of the most devastating genetically defined cardiovascular and central…
LEXEO Therapeutics is a startup Other company (~52 employees) headquartered in United States, with 0 open roles listed on InterviewOS right now. Public records show 2 H-1B petitions approved by USCIS in FY2022-2023 and 1 Labor Condition Application certified in FY2026.
Is LEXEO Therapeutics hiring? Not currently — no live openings on their board.
Does LEXEO Therapeutics sponsor H-1B visas? Yes — 2 petitions approved FY2022-2023; 1 LCA certified FY2026.
Hiring activity at LEXEO Therapeutics
New listings added per week, as discovered by the InterviewOS pipeline
LEXEO Therapeutics has sponsored work visas
Past H-1B petitions and Labor Condition Applications in public government records
Based on public USCIS and Department of Labor records. Past filings do not guarantee future sponsorship. Browse all H1B sponsors →
Quick answers about LEXEO Therapeutics
Factual answers from the data on this page
Does LEXEO Therapeutics sponsor H-1B visas?
Public government records show 2 H-1B petitions approved for LEXEO Therapeutics in FY2022-2023 and 1 Labor Condition Application certified in FY2026. Past filings do not guarantee future sponsorship.
Is LEXEO Therapeutics hiring right now?
InterviewOS is not currently tracking any open roles at LEXEO Therapeutics.
How many people work at LEXEO Therapeutics?
LEXEO Therapeutics employs roughly 52 people, headquartered in United States.
Similar companies
InterviewOS is a job-search platform: you favorite companies, and it watches their boards daily, scores every new role against your resume, and tracks your applications. These statistics come from the same engine. How it works →
See which of these 0 roles match your resume
InterviewOS scores every LEXEO Therapeutics opening against your experience and shows you the roles where you actually stand a chance — free to start.
Sign up free